2020-05-21, 13:18
NIH-funded i3 Center formed to advance cancer immunotherapy
Harvard’s Wyss Institute will collaborate with other institutions to form the i3 Center where cancer immunologists and biological engineers will develop new biomaterials-based approaches to enable anti-cancer immune-therapies for therapy-resistant cancers.
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication
Harvard’s Wyss Institute will collaborate with other institutions to form the i3 Center where cancer immunologists and biological engineers will develop new biomaterials-based approaches to enable anti-cancer immune-therapies for therapy-resistant cancers.
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication